Marshe Turner
Adult Health · Memphis, TNNPI 1407090889
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (33.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Gilead accounts for 81.0% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $9,288, 3.3 times the $2,777 reported in 2021. Among adult health clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $71.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$17K
- Viiv Healthcare Company$2K
- Merck$904
- Johnson & Johnson$416
- Janssen Products, LP$243
- Janssen Scientific Affairs, LLC$159
- plus $260 from 5 others
Across 9 payments — averaging $129.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$1K
What the payments were for
- Consulting fees$4,39020%
- Speaking & faculty fees$7,21534%
- Travel & lodging$2,56612%
- Food & beverage$7,12333%
- Education$1571%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 120 | $17,366 |
| Viiv Healthcare Company | 93 | $2,103 |
| Merck | 42 | $904 |
| Johnson & Johnson(2 entities) | 25 | $416 |
| Janssen Products, LP | 4 | $243 |
| Janssen Scientific Affairs, LLC | 8 | $159 |
| AbbVie | 3 | $157 |
| Novo Nordisk | 3 | $53 |
| Pfizer | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,451 in reported general payments places this provider in the 95th percentile of 352 adult health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 126 | $516,461 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 36 | $141,069 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 12 | $64,654 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 17 | $64,599 |
| JanuviaSitagliptin Phosphate | 12 | $10,091 |
| XareltoRivaroxaban | 12 | $6,371 |
| Atorvastatin Calcium | 72 | $575 |
| Omeprazole | 32 | $509 |
| Gabapentin | 38 | $409 |
| Pravastatin Sodium | 19 | $342 |
| Amlodipine Besylate | 62 | $249 |
| Metformin Hcl ErMetformin Hcl | 29 | $214 |
| Chlorthalidone | 26 | $204 |
| Losartan Potassium | 12 | $197 |
| Pregabalin | 11 | $187 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya | $17,366 | $581,060143 claims |
| Viiv Healthcare CompanyTriumeq | $2,103 | $141,06936 claims |
| Janssen Products, LPSymtuza | $243 | $64,65412 claims |
| MerckJanuvia | $904 | $10,09112 claims |
| Johnson & JohnsonXarelto | $416 | $6,37112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 352 adult health providers in Tennessee.
Other adult health in Memphis
- Artangela HenryMemphis$74K
- Terrye MastinMemphis$34K
- Quaneshia FarrisMemphis$10K
- Brenda BaxterNashville$246K
- Luisa LealNashville$49K
- Robbie LeinartKnoxville$48K
- Sonya KnightSevierville$17K
- Emily LeidigBristol$17K
- Tamera PaceNashville$16K
- Jocelyn McGuireClarksville$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.